Your Cholesterol Number Is the Wrong Number

March 23, 2026 · 9 min read

Two people can have identical LDL numbers and completely different cardiovascular risk. ApoB measures the number of particles. LDL-C measures the cholesterol inside them. Your doctor might be measuring the wrong thing.

Your doctor said your cholesterol is fine. Or your doctor said it's high. Either way, you probably went home and changed nothing, or changed everything. The number felt definitive.

Here is what the research says: LDL-C -- the number on your panel -- is not the metric that best predicts cardiovascular events. Researchers now measure something else entirely. The medical mainstream has started to move. Most patients have not heard.

The lie: one number tells the story

"Your LDL is high" -- or "Your LDL is fine" -- as if that one number tells the cardiovascular story. It tells part of it. Current research has moved on. Most routine blood panels have not.

LDL-C has been the centerpiece of cardiovascular risk assessment for decades. It is on every routine blood panel. Doctors use it to prescribe statins. Patients use it to evaluate their health. The problem is not that LDL matters. It does. The problem is what LDL-C actually measures -- and what it misses.

What LDL-C actually measures

LDL-C measures the amount of cholesterol carried inside LDL particles. It does not measure the number of particles. It does not measure their size. It does not measure whether they are oxidized or damaged.

Two people can have identical LDL-C numbers and completely different cardiovascular risk profiles. One person may have fewer, larger particles. Another may have many small, dense ones. Their LDL-C reads the same. Their arterial walls are experiencing something very different.

This is not a fringe observation. It is why cardiologists and lipidologists increasingly look past LDL-C to more direct measures of risk.

ApoB: the number that actually counts particles

ApolipoproteinB -- ApoB -- is a protein attached to every atherogenic particle in the blood. Every LDL particle carries exactly one ApoB molecule. So does every VLDL remnant, every IDL, every lipoprotein(a).

That means ApoB is a direct count of the particles that can embed in arterial walls. Not the cholesterol inside them. The particles themselves.

A person can have normal LDL-C but elevated ApoB. Their particles are numerous but small. They carry less cholesterol per particle, so LDL-C reads low. But the number of particles -- the actual traffic hitting the arterial wall -- is high. The LDL-C test says they are fine. The ApoB test says they are not.

5% relative reduction in cardiovascular mortality for every 10 mg/dL reduction in ApoB Meta-analysis of 332,912 patients, 2025. The National Lipid Association now recommends ApoB targets alongside LDL-C.

The National Lipid Association now recommends measuring ApoB alongside LDL-C. A growing number of cardiologists consider it the superior target for treatment decisions. It is not yet on most routine panels. You have to ask.

Small dense LDL: the particle that does the damage

Not all LDL particles are equal. Small dense LDL (sdLDL) penetrates arterial walls more easily than large, buoyant LDL. Small dense particles oxidize more readily. Oxidized LDL triggers the inflammatory cascade that builds plaques.

Large buoyant LDL -- sometimes called Pattern A -- is largely benign. Small dense LDL -- Pattern B -- is the one associated with cardiovascular events. A standard LDL-C panel does not distinguish between them.

What creates a small dense particle profile:

A person eating high-sugar, low-fiber, processed food can have normal LDL-C and a particle profile that is actively damaging. Their panel looks fine. The mechanism does not.

Inflammation: the predictor that beats LDL-C

High-sensitivity C-reactive protein -- hs-CRP -- is a blood marker for systemic inflammation. It is not a lipid. It is a signal that the immune system is activated, that something in the body is under chronic stress.

In 2024, Circulation published the 30-year follow-up of 27,939 women from the Women's Health Study. The findings were striking.

1.70 hazard ratio for cardiovascular events from elevated hs-CRP (inflammation) vs. 1.36 for elevated LDL-C. Inflammation was the stronger predictor. Circulation, 2024, 27,939 women, 30-year follow-up.

Inflammation was the stronger predictor. Not cholesterol.

Statins lower LDL. They also lower hs-CRP -- they have anti-inflammatory effects independent of their lipid-lowering action. Some researchers believe the cardiovascular benefit of statins comes partly from inflammation reduction, not just from moving the LDL number. The question this raises: if inflammation is as important as LDL, why does every conversation about heart health focus almost entirely on the cholesterol panel?

The TG/HDL ratio: the hidden metabolic marker

The triglyceride-to-HDL ratio is one of the best proxies for insulin resistance and metabolic syndrome in routine blood work. It is rarely discussed in clinical conversations. It is almost never the focus of dietary advice.

A TG:HDL ratio above 3.5 is associated with significantly elevated cardiovascular and metabolic risk. A ratio below 2.0 is generally considered favorable. These are numbers that appear on every standard lipid panel -- they are already in your results. Most people have never been told to look at them together.

What moves TG/HDL in the right direction: fiber, omega-3 fatty acids, fewer refined carbohydrates, less ultra-processed food. These are not exotic interventions. They are the same things that characterize a whole-food diet.

What Hestia's Ember Score actually optimizes for

Here is where this connects to something practical.

Hestia's Ember Score was not built around LDL targets. It was built around food quality signals:

Every one of those signals is an upstream driver of the markers that predict cardiovascular risk: ApoB particle count, small dense LDL formation, hs-CRP inflammation, and TG/HDL ratio.

The system was not designed to lower a cholesterol number. It was designed to build a week around whole ingredients. Research links whole-food eating to lower inflammation, better triglyceride profiles, and improved particle quality. A Hestia plan is built around those foods. Not as a health claim. As a food philosophy.

See what a whole-food week actually looks like

Fish, legumes, olive oil, fiber. Real meals, planned before you shop. Priced before you go.

See a sample plan

What to actually ask your doctor

Three questions worth adding to your next appointment:

These three numbers, alongside LDL-C, give a much fuller picture. Most doctors will not order them without being asked. Most panels do not include hs-CRP or ApoB by default.

This is not a case against your doctor. It is a case for asking better questions. LDL-C is not useless. It is incomplete. The research has moved. The routine panel has not caught up.

There are households eating whole food -- fish twice a week, legumes in the rotation, olive oil as the default fat, fiber at every meal -- not because they read a cardiology paper. Because that is just what a real week of cooking looks like when you plan it out.

Their TG/HDL ratio is better than their neighbor's. Their hs-CRP is lower. Their particle profile reflects it. None of them asked for that. It came with the food.

The ultra-processed version of the same week -- same calories, same apparent effort -- produces a different set of numbers. Not dramatically. Just consistently, across years.

Week 5 changes everything. It always does.

Whole food. Planned before you shop.

Fish, legumes, olive oil, fiber. A Hestia week is built around ingredients research links to better cardiovascular markers -- because that is what real cooking looks like.

Get Started Free

Free to try. No credit card required.